Ann Richmond

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 13

Top Venues

Cancers

International journal of molecular sciences

Journal of the National Cancer Institute

NPJ precision oncology

Vanderbilt University

Emory University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vanderbilt University Aug 01 2018

United States

Professor :: Department of Pharmacology

Education History

Emory University Sep 05 1976 - Oct 29 1979

United States

PHD :: Biology

Publications

Kennady K Bullock, Ann Richmond
Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer. Cancers 16 (12) (2024)
Kennady K Bullock, Ann Richmond
Beyond Anti-PD-1/PD-L1: Improving Immune Checkpoint Inhibitor Responses in Triple-Negative Breast Cancer. Cancers 16 (12) (2024)
Chi Yan, Caroline A Nebhan, Nabil Saleh, Rebecca Shattuck-Brandt, Sheau-Chiann Chen, Gregory D Ayers, Vivian Weiss, Ann Richmond, Anna E Vilgelm
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma. Cancers 15 (14) (2023)
Pataje G S Prasanna, Deborah E Citrin, Jeffrey Hildesheim, Mansoor M Ahmed, Sundar Venkatachalam, Gabriela Riscuta, Dan Xi, Guangrong Zheng, Jan van Deursen, Jorg J Goronzy, Stephen J Kron, Mitchell S Anscher, Norman E Sharpless, Pierre-Yves Desprez, Stephen L Brown, Laura J Niedernhofer, Ana O'Loghlen, Alexandros G Georgakilas, François Paris, David Gius, David A Gewirtz, Clemens A Schmitt, Mohamed E Abazeed, James L Kirkland, Ann Richmond, Paul B Romesser, Scott W Lowe, Jesús Gil, Marc S Mendonca, Sandeep Burma, Daohong Zhou, C Norman Coleman
Therapy-Induced Senescence: Opportunities to Improve Anticancer Therapy. Journal of the National Cancer Institute 113 (10) (2022)
Chi Yan, Sheau-Chiann Chen, Gregory D Ayers, Caroline A Nebhan, Joseph T Roland, Vivian L Weiss, Douglas B Johnson, Ann Richmond
Proximity of immune and tumor cells underlies response to BRAF/MEK-targeted therapies in metastatic melanoma patients. NPJ precision oncology 6 (1) (2022)
Zhizhu Zhang, Ann Richmond, Chi Yan
Immunomodulatory Properties of PI3K/AKT/mTOR and MAPK/MEK/ERK Inhibition Augment Response to Immune Checkpoint Blockade in Melanoma and Triple-Negative Breast Cancer. International journal of molecular sciences 23 (13) (2022)
Kennady K Bullock, Ann Richmond
Suppressing MDSC Recruitment to the Tumor Microenvironment by Antagonizing CXCR2 to Enhance the Efficacy of Immunotherapy. Cancers 13 (24) (2021)
Sarah J Kurley, Verena Tischler, David M Bierie, Sergey V Novitskiy, Aurelia Noske, Zsuzsanna Varga, Ursina Zürrer-Härdi, Simone Buchardt Brandt, Robert H Carnahan, Rebecca S Cook, William J Muller, Ann Richmond, Albert B Reynolds
A requirement for p120-catenin in the metastasis of invasive ductal breast cancer. Journal of cell science 134 (6) (2021)
Chi Yan, Jinming Yang, Nabil Saleh, Sheau-Chiann Chen, Gregory D Ayers, Vandana G Abramson, Ingrid A Mayer, Ann Richmond
Inhibition of the PI3K/mTOR Pathway in Breast Cancer to Enhance Response to Immune Checkpoint Inhibitors in Breast Cancer. International journal of molecular sciences 22 (10) (2021)
Carly Bess Scalise, Caroline A Nebhan, Jinming Yang, Lauren S Starnes, Chi Yan, Anna E Vilgelm, Sheau-Chiann Chen, Gregory Dan Ayers, Vandana Abramson, Ingrid A Mayer, Ann Richmond
Correlative studies investigating effects of PI3K inhibition on peripheral leukocytes in metastatic breast cancer: potential implications for immunotherapy. Breast cancer research and treatment 184 (2) (2020)
Rebecca L Shattuck-Brandt, Sheau-Chiann Chen, Emily Murray, Christopher Andrew Johnson, Holly Crandall, Jamye F O'Neal, Rami Nayef Al-Rohil, Caroline A Nebhan, Vijaya Bharti, Kimberly B Dahlman, Gregory D Ayers, Chi Yan, Mark C Kelley, Rondi M Kauffmann, Mary Hooks, Ana Grau, Douglas B Johnson, Anna E Vilgelm, Ann Richmond
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (14) (2020)
Jinming Yang, Chi Yan, Anna E Vilgelm, Sheau-Chiann Chen, Gregory D Ayers, Christopher A Johnson, Ann Richmond
Targeted Deletion of CXCR2 in Myeloid Cells Alters the Tumor Immune Environment to Improve Antitumor Immunity. Cancer immunology research 9 (2) (2020)
Anna E Vilgelm, Nabil Saleh, Rebecca L Shattuck-Brandt, Kelsie Riemenschneider, Lauren Slesur, Sheau-Chiann Chen, Christopher A Johnson, Jinming Yang, Ashlyn N Blevins, Chi Yan, Douglas B Johnson, Rami Nayef Al-Rohil, Ensar Halilovic, Rondi M Kauffmann, Mark Kelley, Gregory D Ayers, Ann Richmond
MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21. Science translational medicine 11 (505) (2020)

Ann Richmond.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Ann Richmond